This week is the last chance to save $367 on your attendance!
Explore registration options before time runs out.
Welcome to the Inaugural Autoimmune & Inflammatory Models Summit
Navigate Model Selection, Improve Translatability, Prepare for IND Submission
In 2025, investment in autoimmune and inflammatory disease R&D is surging, however, 90% of therapies still fail in the clinic due to poor model translatability. Success now hinges on tools that can better predict efficacy, de-risk pipelines, and align with evolving FDA expectations.
The Autoimmune & Inflammatory Models Summit is the only industry-driven meeting uniting leading pharma and biotech minds to share real world-case studies and cutting-edge strategies to advance translatable autoimmune and inflammatory models.
Explore how leaders like AbbVie, Pfizer, and Seismic Therapeutics are advancing complex models for target discovery, biomarker validation, and IND success, turning scientific insights into clinical wins.
Our World-Class Speaker Faculty Includes:





